Mucinous adenocarcinoma of the prostate: case report and review of the literature

Alexander Georgiev Otsetov 1, Kalin Kalchev 2, Natasha Takova 3, Alexander Hinev 4

Abstract


Background: Mucinous adenocarcinoma of the prostate (MACP) is a rare variant of prostatic carcinoma that is characterized by pools of extra-acinar mucin. Precise diagnosis is important due to nonspecific findings on imaging tests, its aggressive behaviour and poor response to radiotherapy. The essential point in the diagnosis of MACP is to rule out the extraprostatic malignancies, originating from the bladder or colorectum.

Case Report: A 57-year-old man presented in our clinic with urinary frequency, nocturia and voiding difficulties. Digital rectal examination revealed a slightly enlarged prostate, without palpable nodules. Patient PSA was 18.0 ng/mL. Twelve-core transrectal ultrasound-guided biopsy confirmed prostate cancer with Gleason score 8 (3+4). Up to 50% of the tumor lesion consisted of neoplastic glands with isolated cells, floating in mucinous material. The metastatic work-up, including CT scan and bone scintigraphy was negative and radical retropubic prostatectomy with lymph node dissection has been performed. Periodic Acid Schiff staining confirmed the presence of mucinous prostatic adenocarcinoma. Morphological examination was negative for lymph nodes metastases. The extraprostatic extension and surgical margins were negative. Three years after surgery, patient’s serum PSA remained undetectable, without recurrence.  

Conclusion: We report this case due to the rarity of primary MACP and its challenging diagnosis. Although MACP may be associated with poor outcome, its proper diagnosis and treatment significantly contribute to favorable prognosis and patient survival. 


Keywords


Prostate cancer; Mucinous Adenocarcinoma; Mucin

Full Text:

PDF

References


Fletcher CDM. Diagnostic histopathology of tumors. Churchill–Livingstone Elsevier 2008; 778–9.

Elbadawi A, Craig W, Linke CA, et al. Prostatic mucinous carcinoma. Urology 1979; 13: 658-66.

Epstein JI, Lieberman PH. Mucinous adenocarcinoma of the prostate gland. Am J Surg Pathol 1985; 9: 299-308.

Humphrey P, Amin MB, Berney D, et al. Pathology and genetics: Tumors of the urinary system and male genital organs. WHO classification of tumors. 4th ed. Zurich, Switzerland: IARC Press, 2016; 136–150.

Grignon DJ. Unusual subtypes of prostate cancer. Modern Pathology 2004; 17: 316–327.

Epstein JI, Allsbrook WC Jr, Amin MB, et al. the ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am. J. Surg. Pathol. 2005; 29: 1228–1242.

Epstein JI, Egevad L, Amin MB, et al.; the ISUP Grading Committee. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: Definition of grading patterns and proposal for a new grading system. Am. J. Surg. Pathol. 2016; 40: 244–252.

Samaratunga H, Delahunt B, Srigley J R, et. al. Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: A clinicopathological analysis of 143 cases. Histopathology 2017; 71: 641–647.

Osunkoya AO, Epstein JI. Primary mucin-producing urothelial-type adenocarcinoma of prostate: Report of 15 cases. Am J Surg Pathol 2007; 31: 1323-9.

Osunkoya AO, Nielsen ME, Epstein JI. Prognosis of mucinous adenocarcinoma of the prostate Treated by radical prostatectomy. Am J Surg Pathol 2008; 32: 468-72.

Enciu M, Aschie M, Deacu M, et al. Morphological characteristics of a mucinous adenocarcinoma of the prostate: Differential diagnosis considerations. Rom J Morphol Embryol 2013; 54: 191-4.

McNeal JE, Alroy J, Villers A, et al. Mucinous differentiation in prostatic adenocarcinoma. Hum Pathol 1991; 22: 979–88.

Grignon DJ. Unusual subtypes of prostate cancer. Modern Pathology 2004; 17: 316–327.

Westphalen AC, Fergus V, et al. Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy features. Am J Roentgenol 2009; 193: W238-327.

Outwater E, Schiebler ML, Tomaszewski JE, et al. Mucinous carcinomas involving the prostate: Atypical findings at MR imaging J. Magn. Reson. Imaging 1992; 2: 597–600.

Pokorny MR, de Rooij M, Duncan E, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur. Urol. 2014; 66: 22–29.

Ro JY, Grignon DJ, Ayala AG, et al. Mucinous adenocarcinoma of the prostate: Histochemical and immunohistochemical studies. Hum. Pathol. 1990; 21: 593–600.

Johnson H, Zhou M, Osunkoya AO. ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: Comparison with conventional prostatic adenocarcinoma. Hum. Pathol. 2013; 44: 2241–2246.

Han B, Mehra R, Suleman K, et al. Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma. Mod. Pathol. 2009; 22: 1176–1185.

Osunkoya AO, Adsay NV, Cohen C, et al. MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: An analysis of 50 cases on radical prostatectomy. Mod. Pathol. 2008; 21: 789–794.




DOI: http://dx.doi.org/10.24294/mipt.v0i0.207

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Medical Imaging Process & Technology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License

This site is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.